{"id":"NCT01704261","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)","officialTitle":"A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Safety and Efficacy of the Addition of MK-3102 to Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10-18","primaryCompletion":"2014-12-23","completion":"2014-12-23","firstPosted":"2012-10-11","resultsPosted":"2015-11-25","lastUpdate":"2018-09-10"},"enrollment":307,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Omarigliptin","otherNames":[]},{"type":"DRUG","name":"Matching placebo to Omarigliptin","otherNames":[]},{"type":"DRUG","name":"Glimepiride","otherNames":["Amaryl®","Glimy"]},{"type":"DRUG","name":"Metformin","otherNames":["Fortamet®","Glucophage®","Glucophage® XR","Glumetza®","Riomet®"]}],"arms":[{"label":"Omarigliptin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will examine the safety and efficacy of the addition of omarigliptin in participants with type 2 diabetes mellitus with inadequate glycemic control on metformin and glimepiride. The primary hypothesis is that after 24 weeks, the addition of treatment with omarigliptin provides a greater reduction in hemoglobin A1c (A1C) compared with the addition of placebo.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (A1C) at Week 24","timeFrame":"Baseline and Week 24","effectByArm":[{"arm":"Omarigliptin","deltaMin":-0.67,"sd":null},{"arm":"Placebo","deltaMin":-0.06,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["29110647"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":153},"commonTop":["Hypoglycaemia","Upper respiratory tract infection","Urinary tract infection"]}}